127
Participants
Start Date
October 31, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
December 31, 2009
ALD518
Two doses of ALD518, each given in an infusion of normal saline, IV over 1 hour, at Weeks 1 and 8
Infusion without ALD518'
250 cc Normal saline IV over one hour Weeks 1 and 8.
Institute of Rheumatology, Belgrade
Institute for Rehabilitation and Treatment Niska Banja, Niška Banja
Clinical Hospital of Emergency Care named after N.V. Solovyev, Yaroslavl
Saint Petersburg Medical Academy of Postgraduate Study, Saint Petersburg
Saint-Petersburg State Medical Academy named after I. I. Mechnikov, Saint Petersburg
City Hospital #26, Saint Petersburg
Tula Regional Clinical Hospital, Tula
Ryazan Regional Clinical Cardiologic Dispensary, Ryazan
Regional War Veterans' Hospital, Saratov
Institute of Clinical and Experimental Lymphology, Novosibirsk
Tomsk Regional Clinical Hospital, Tomsk
Regional Clinical Hospital of War Veterans, Kemerovo
K-W Musculoskeletal Research, Inc., Kitchener
Rheumatology Research Associates, Ottawa
V. Tsitlanadze Scientific Practical Centre of Rheumatology, Tbilisi
Medulla Chemotherapy and Immunotherapy Clinic, Tbilisi
Chanre Rheumatology and Immunology Center and Research, Malleshwaram
KLE Society Hospital and Medical Research Centre, Nehru Nagar
Sushrut Hospital, Research Centre & Post Graduate Institute of Orthopaedics, Ramadaspeth
St. John's Medical College Hospital, Bangalore
Krishna Institute of Medical Sciences Ltd., Secunderabad
Miriada Center Private Clinic of Professor Sierakowski, Bialystok
Nonpublic Centre of Medical Care Reumed, Lublin
NOVAMED - Medical Center of Poznan, Poznan
Provincional Rheumatological Complex named after Dr Jadwiga Titz-Kosko, Sopot
Szezecin Clinic of Rheumatology and Internal Diseases, Szczecin
Lead Sponsor
CSL Behring
INDUSTRY